New immune cell therapy tested for Tough-to-Treat brain cancer
Disease control
Terminated
This early-stage trial is testing the safety and initial effects of a new type of CAR-T cell therapy for adults with aggressive brain tumors (grade 4 glioma) that have returned or not responded to standard treatments. The therapy involves modifying a patient's own immune cells to…
Phase: PHASE1 • Sponsor: Yang Zhang • Aim: Disease control
Last updated Mar 13, 2026 15:05 UTC